Vitamin C

Typical form: Ascorbic Acid

Recommended test

Uric Acid

Vitamin C is uricosuric — it increases the kidneys' excretion of uric acid — and has also been shown to inhibit urate production in animal models. It's used here sparingly and occasionally, in two situations specifically: as a buffer when uric acid is elevated but hasn't progressed to diagnosed gout, and as general antioxidant/oxidative-stress support during acute illness — rather than as an ongoing daily supplement.

An important population distinction: the evidence for vitamin C lowering uric acid is strongest in people with elevated levels who don't yet have gout. Once gout is already established, the picture changes — see below.

Common form & typical benefits

Ascorbic Acid

The standard, most-studied form used in essentially all the uric acid research
Works by increasing urinary excretion of urate (uricosuric effect) and by dissolving urate crystals at the molecular level

Research noteA meta-analysis of 13 RCTs (556 people, median dose 500 mg/day, median duration 30 days) found a significant reduction in serum uric acid. A large, long-running RCT (the Physicians' Health Study II, over 14,600 men followed up to 10 years) found 500 mg/day vitamin C reduced new gout diagnoses by 12% — a modest but statistically real effect, strongest in people with a healthy BMI.

What the research says

Evidence by outcome

Outcome	Approx. evidence base	Typical finding
Serum uric acid, general/hyperuricemic population	Meta-analysis, 13 RCTs (556 people)	Significant reduction (~-20.8 μmol/L average)
New gout diagnoses (prevention)	RCT, 14,641 men, up to 10 years	12% reduction in new gout diagnoses — modest, real, strongest in lower-BMI participants
Established gout (already diagnosed)	RCT, 40 gout patients, 8 weeks	No clinically significant urate-lowering effect — a real gap between this population and the others above
Cold duration/severity, regular use before illness	Large meta-analyses (11,000+ people)	Modest reduction in duration (~8% adults, 14-18% children) and severity (~15%)
Cold duration/severity, started after symptoms begin	7 trial comparisons (3,249 illness episodes)	No consistent effect found

This is a clean, honest story worth stating plainly: vitamin C helps in the earlier stages — elevated uric acid without gout, or reducing the risk of it developing in the first place. Once someone already has diagnosed gout, the same dose stopped working in the one trial that tested it directly, even though it still raised their vitamin C levels — the uricosuric effect is real but too small to matter once gout is established. That's a meaningful population distinction, not just a dose question.

On illness use specifically: the cold-duration/severity research above is included as context, but it's not the basis for how this is used here. The rationale for illness use is vitamin C's general role as an antioxidant, supporting the body's oxidative-stress response during acute illness — not a specific claim about shortening how long someone is sick. Worth being direct that the "shortens colds" evidence specifically requires regular use started before symptoms, which is a different protocol than occasional, reactive use.

Research summary chart

View PDF ↗

Dosages used in studies

What the research actually tested

Goal	Typical dose	Notes	Duration
Practitioner-used dose (this site)	500 mg	Matches the research dose directly; used sparingly/occasionally, not as an ongoing daily regimen	As needed — uric acid buffer or acute illness
Uric acid reduction / gout prevention (research)	500 mg/day	The dose used across nearly all the positive trials	30 days–10 years
Established gout (didn't work at this dose)	500 mg/day	Whether a higher dose would work is untested	8 weeks

Safety notes & high-dose risks

What to watch for

Kidney stone risk at high doses — vitamin C is metabolized partly into oxalate, and high-dose supplementation (well above the 500 mg/day studied here) has been linked to increased kidney stone risk, particularly in people prone to oxalate stones.
GI upset at high doses: loose stools/diarrhea is the classic "bowel tolerance" limit — a sign to reduce the dose, not a dangerous reaction.
Rare but serious: G6PD deficiency — very high-dose vitamin C (mainly relevant to IV administration, not typical oral doses) can trigger hemolysis in people with this genetic condition.
At the 500 mg/day dose used in essentially all the research above, vitamin C has an excellent safety record.

Additional notes

Worth knowing

Population matters more than dose here: the honest read of the research is "helpful before/without gout, not proven once gout is established" — not simply "take more if it's not working."
Connects to the Iron marker too: vitamin C enhances absorption of non-heme iron — worth knowing if both markers are being addressed at once, since timing them together could meaningfully help the Iron protocol.
Used situationally, not as an ongoing regimen: reached for sparingly — as a uric acid buffer or for oxidative-stress support during illness — rather than taken daily on a fixed schedule.
Retesting: uric acid roughly 4-6 weeks after use is a reasonable check-in point — shorter than the 8-12 week window used elsewhere in this library, matching the shorter, situational way this is actually used.

Shop on Fullscript Shop on Prodrome

Educational information only — not medical advice. Lab testing and any supplementation decisions should be made with a qualified healthcare provider who knows your personal health history. Research findings vary by population, dose, form, and study quality.

Some links go to Fullscript, where I may earn a commission at no extra cost to you. I only recommend supplements I've either used myself or seen work in my clients' lab data. Results vary from person to person.